MAPK8 and glioblastoma: On the other hand, 3-(5-methoxy-2-methyl-1H-indol-3-yl)-1-(4-pyridinyl)-2-propene-1-one (MOMIPP) induces methuosis in glioblastoma and other cancer cell lines by modulating the MAPK/Jun N-Terminal Kinase (JNK) signalling pathway [29].